Sicart Associates Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$9.57M |
| 2 |
Albemarle
ALB
|
+$5.5M |
| 3 |
Gilead Sciences
GILD
|
+$4.19M |
| 4 |
Bunge Global
BG
|
+$3.84M |
| 5 |
Intel
INTC
|
+$482K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$2.67M |
| 2 |
NXP Semiconductors
NXPI
|
+$2.44M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$2.37M |
| 4 |
CTXS
Citrix Systems Inc
CTXS
|
+$603K |
| 5 |
Crown Castle
CCI
|
+$531K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.12% |
| 2 | Materials | 10.81% |
| 3 | Consumer Staples | 10.63% |
| 4 | Technology | 8.84% |
| 5 | Communication Services | 8.81% |
Similar funds
Sicart Associates's Q3 2020 Portfolio in Review
As of Q3 2020, Sicart Associates held 125 positions worth $335M, up 7.1% from $313M the previous quarter. Its ten largest holdings account for 50% of the portfolio.
Sicart Associates deployed $13.8M of net new capital in Q3 2020, opening 17 new positions and adding to 14 existing holdings. Its largest new stake was iPath Series B S&P 500 VIX Short-Term Futures ETN: 5,386 shares worth $8.58M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 24% a quarter earlier, followed by Materials and Consumer Staples.
On the sell side, the largest reduction was Citrix Systems Inc, an estimated $603K trimmed.
- Sicart Associates's largest Q3 2020 buy was iPath Series B S&P 500 VIX Short-Term Futures ETN: 5,386 shares worth $8.58M.
- Sicart Associates added most to Albemarle in Q3 2020, an estimated $5.5M increase.
- Sicart Associates's biggest Q3 2020 reduction was Citrix Systems Inc, cutting an estimated $603K.
- Sicart Associates fully exited Nuance Communications, Inc. in Q3 2020, selling an estimated $2.67M.
- Sicart Associates's ten largest holdings make up 50% of its $335M portfolio in Q3 2020.
- Sicart Associates opened 17 new positions and closed 9 in Q3 2020.
- Sicart Associates's portfolio value rose 7.1% quarter-over-quarter to $335M.
Based on Sicart Associates's 13F filing for Q3 2020, filed 14 Oct 2020.